1h Free Analyst Time
The marine biotechnology market is forecasted to grow by USD 5.53 billion during 2024-2029, accelerating at a CAGR of 10.5% during the forecast period. The report on the marine biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in demand for biofuel, increased demand for secondary metabolites from marine microorganisms, and rising demand for natural compounds in the cosmetic industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The marine biotechnology market is segmented as below:
By Application
- Healthcare products
- Energy and environment management products
- Food and cosmetics products
By Type
- Bio active substance
- Bio materials
- Others
By Source
- Algae
- Marine fungi
- Corals and sponges
- Marine viruses
- Others
By Technology
- Isolation and cultivation of microorganisms
- Culture-independent techniques
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the marine biotechnology market covers the following areas:
- Marine Biotechnology Market sizing
- Marine Biotechnology Market forecast
- Marine Biotechnology Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Type
10 Market Segmentation by Source
11 Market Segmentation by Technology
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global marine biotechnology market: Air Liquide SA, Aker BioMarine ASA, AlgaEnergy SA, Archer Daniels Midland Co., BASF SE, CoDo International Ltd., Cyanotech Corp., FMC Corp., Geomarine Biotechnologies, Glyco Mar Ltd., J M Huber Corp., KD Pharma Group, Lonza Group Ltd., Marinomed Biotech AG, Marinova Pty Ltd., Marshall Marine Products, New England Biolabs Inc., PharmaMar SA, and Prolume Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing concern about climate change."
According to the report, one of the major drivers for this market is the increase in demand for biofuel.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Air Liquide SA
- Aker BioMarine ASA
- AlgaEnergy SA
- Archer Daniels Midland Co.
- BASF SE
- CoDo International Ltd.
- Cyanotech Corp.
- FMC Corp.
- Geomarine Biotechnologies
- Glyco Mar Ltd.
- J M Huber Corp.
- KD Pharma Group
- Lonza Group Ltd.
- Marinomed Biotech AG
- Marinova Pty Ltd.
- Marshall Marine Products
- New England Biolabs Inc.
- PharmaMar SA
- Prolume Ltd.
